About Harmony test

The Harmony prenatal test is backed by Roche
The Harmony non-invasive prenatal test from Roche
Since its introduction in 2012, the Harmony non-invasive prenatal test (NIPT) has emerged as one of the pioneering options in prenatal screening tests. Supported by Roche's long-standing dedication and over 125 years of service, the Harmony test provides the accuracy and reliability you have come to expect from Roche products. Moreover, it is the most extensively studied NIPT available, proven to surpass traditional screening methods with exceptional performance.1
More about Roche
Roche has been a trusted healthcare pioneer for over 125 years. As a front-runner in personalized healthcare and in-vitro diagnostics, Roche drives innovation and advancements in these fields. As the world’s leading biotechnology company, Roche is proud to be entrusted with 100,000 instrument placements2 and 27 billion tests annually worldwide.2 These achievements are made possible by a dedicated team of over 101,000 employees3 across more than 100 countries worldwide.2
Roche in numbers
Because when it comes to your baby’s health, trust is everything!
Why the Harmony Test?
Trusted by patients worldwide, the Harmony test is available in more than 100 countries and used in more than 2 million pregnancies.4 It stands as the most extensively studied cell-free DNA test in the market, with more than 330,000 patient samples included in over 78 peer-reviewed publications.5 In comparison to traditional screening tests like first-trimester screening, the Harmony test offers enhanced accuracy and a lower false positive rate , providing you and your patients with peace of mind and confidence in first-line screening results.1


  1. Norton et al. New Engl J of Med. 2015; 372(17):1589-1597.
  2. https://www.roche.com/about/business/diagnostics; Accessed September 2023
  3. https://careers.roche.com/global/en; Accessed September 2023
  4. Data on file at Roche.
  5. Demonstrated by 78 peer-reviewed published studies using the Harmony prenatal test as of September 2023. Analytical validation, clinical validation, clinical experience and other studies. Data on file at Roche.